Standard Operating Procedure for Competitive Regulatory Intelligence in Multi-Market Programs
| Department | Regulatory Affairs |
| SOP No. | RA/2026/643 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 09/04/2026 |
| Effective Date | 09/04/2026 |
| Review Date | 09/04/2028 |
Purpose
This Standard Operating Procedure (SOP) provides a systematic approach for conducting competitive regulatory intelligence across multiple markets. It aims to ensure consistent monitoring, analysis, and interpretation of regulatory environments and competitor activities to support informed decision-making and maintain regulatory compliance in the development, registration, and lifecycle management of pharmaceutical products and related activities.
Scope
This SOP applies to all activities related to gathering, processing, and reporting competitive regulatory intelligence for pharmaceutical products and programs across different international and national markets. It encompasses regulatory information sources, competitor product dossiers, market entry strategies, and applicable compliance risks. This SOP excludes internal confidential proprietary business strategy development and non-regulatory competitive business intelligence.
Responsibilities
The following functional roles are responsible under this SOP:
- Regulatory Intelligence Analysts – conducting data collection, research, analysis, and initial reporting.
- Regulatory Affairs Managers – reviewing, approving intelligence reports, and guiding strategy alignment.
- Quality Assurance – verifying compliance with this procedure during audits and reviews.
- Document Control – ensuring proper version management and archiving of intelligence documentation.
- Cross-functional Team Leads – incorporating regulatory intelligence findings into project planning.
Accountability
The Head of Regulatory Affairs is accountable for ensuring implementation, adherence, periodic review, escalation of issues, and overall effectiveness monitoring of this SOP within assigned regions and products.
Procedure
1. Preparation and Prerequisites:
a. Confirm applicable markets and products within the scope of the intelligence activity.
b. Ensure all team members have access to required regulatory databases, subscription services, and internal document repositories.
c. Review the latest regulatory updates, guidance documents, and competitor product approvals relevant to monitored markets.
2. Data Collection:
a. Systematically gather information from credible sources including regulatory agency websites, submission databases, published guidelines, and competitor communications.
b. Monitor market entry notifications, dossier filings, label changes, post-marketing commitments, and withdrawal notices.
c. Collect information on regulatory timelines, inspection outcomes, compliance warnings, and legal or policy changes affecting registrations.
3. Data Analysis and Interpretation:
a. Evaluate the impact of regulatory changes on current and planned submissions.
b. Compare competitor product statuses, formulations, and regulatory pathways.
c. Identify emerging trends, potential risks, and opportunities in regulatory environments.
d. Correlate intelligence with internal project milestones and product lifecycle activities.
4. Reporting and Documentation:
a. Prepare comprehensive reports summarizing key findings, market-specific risks, and strategic recommendations.
b. Use standardized templates to facilitate clarity and consistency.
c. Submit reports for managerial review and incorporate feedback.
d. Ensure proper version control and secure storage of all intelligence documentation in the designated document management system.
5. Monitoring and Updates:
a. Establish periodic review cycles and trigger updates upon significant regulatory changes.
b. Maintain communication with cross-functional teams and regulatory agencies for continuous intelligence flow.
c. Document any deviations, corrective actions, and impacts arising during intelligence activities.
6. Approvals and Escalation:
a. Obtain final approval of intelligence reports from Regulatory Affairs Managers.
b. Escalate issues related to compliance gaps, regulatory risks, or intelligence inaccuracies to Head of Regulatory Affairs without delay.
7. Training and Competency:
a. Ensure all personnel involved in regulatory intelligence are trained on this SOP and tools used.
b. Maintain training records and conduct periodic refresher sessions.
This procedure supports adherence to regulatory standards and promotes proactive regulatory risk management in multi-market pharmaceutical programs.
Abbreviations
RA – Regulatory Affairs
SOP – Standard Operating Procedure
QA – Quality Assurance
DMS – Document Management System
PMR – Post-Marketing Requirements
Documents
The following documents are specifically required for executing this SOP:
- Competitive Regulatory Intelligence Report Template (Annexure-1)
- Regulatory Intelligence Data Collection Log (Annexure-2)
- Regulatory Intelligence Review and Approval Form (Annexure-3)
References
International Conference on Harmonisation (ICH) Guidelines
FDA Guidance Documents
EMA Regulatory Procedures
Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S)
Internal Quality Management System and Document Control Procedures
Applicable National Regulatory Authority Publications
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Competitive Regulatory Intelligence Report Template
Purpose: To standardize the reporting format for findings from competitive regulatory intelligence activities across multiple markets.
| Section | Details |
|---|---|
| Report Title | Competitive Regulatory Intelligence Summary – [Market/Region] |
| Date of Report | 09/04/2026 |
| Prepared By | Regulatory Intelligence Analyst |
| Executive Summary | Concise overview of regulatory landscape changes impacting portfolio. |
| Market Overview | Summary of market-specific regulatory context. |
| Competitor Product Status | Current approval and submission status of competitor products. |
| Regulatory Changes | Relevant updates including new guidances, inspection results, compliance notes. |
| Potential Risks / Opportunities | Identified regulatory risks or market advantages for internal consideration. |
| Recommendations | Suggested actions or follow-up steps. |
| Distribution List | Cross-functional recipients of the report. |
| Sign-off | Manager Review: ___________ Date: ___________ |
Annexure-2: Regulatory Intelligence Data Collection Log
Purpose: To log all regulatory intelligence data sources, collection dates, and particulars for traceability and verification.
| Entry No. | Date | Source | Information Type | Summary | Collected By |
|---|---|---|---|---|---|
| 1 | 05/04/2026 | FDA Website | New Drug Approvals | Approval of competitor product X for indication Y | R. Int. Analyst |
| 2 | 06/04/2026 | EMA Newsletter | Guidance Update | Changes in stability requirements for generics | R. Int. Analyst |
| 3 | 07/04/2026 | Internal Regulatory Hub | Dossier Submissions | Status update on competitor filing in market Z | R. Int. Analyst |
Annexure-3: Regulatory Intelligence Review and Approval Form
Purpose: To document the review and approval process of regulatory intelligence reports ensuring accountability and traceability.
| Report Title | Competitive Regulatory Intelligence Summary – [Market/Region] |
|---|---|
| Report Date | 09/04/2026 |
| Prepared By | Regulatory Intelligence Analyst |
| Reviewed By | Regulatory Affairs Manager |
| Review Date | 09/04/2026 |
| Comments/Recommendations | Report reviewed and suitable for distribution. |
| Approved By | Regulatory Affairs Manager |
| Approval Date | 09/04/2026 |
| Signatures | Prepared By: ___________ Reviewed By: ___________ Approved By: ___________ |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 09/04/2026 | 1.0 | Initial issue | New SOP creation |